Overview

Mitoxantrone Hydrochloride Liposome Combined With Chemotherapy in Untreated de Novo Acute Myeloid Leukemia

Status:
Not yet recruiting

Trial end date:
2026-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the safety, efficacy and pharmacokinetics of mitoxantrone hydrochloride liposome injection combined with chemotherapy in previously untreated de novo acute myeloid leukemia.

Phase:

N/A

Details

Lead Sponsor:

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.

Treatments:

Cytarabine
Homoharringtonine
Mitoxantrone
Venetoclax